Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2008-01-25 CARTER STEPHEN Director Grant or award · Non-qualified stock option (right to buy) +5,000 5,000
2008-01-25 CARTER STEPHEN Director Grant or award · Non-qualified stock option (right to buy) +10,000 10,000
2007-12-17 CARTER STEPHEN Director Grant or award · Non-qualified stock option (right to buy) −25,000 25,000

Page 1 of 1 · 3 trades